CM
IRWD icon

Caption Management’s Ironwood Pharmaceuticals IRWD Stock Holding History

Caption Management’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-50,000
Closed -$222K – 1791
2024
Q4 		$222K Buy
+50,000
New +$203K ﹤0.01% 1260
2021
Q4 		– Sell
-15,000
Closed -$196K – 1758
2021
Q3 		$196K Sell
15,000
-161,548
-92% -$2.09M ﹤0.01% 1351
2021
Q2 		$2.27M Buy
176,548
+97,648
+124% +$1.12M 0.03% 642
2021
Q1 		$883K Buy
78,900
+63,787
+422% +$674K 0.02% 707
2020
Q4 		$172K Sell
15,113
-82,387
-84% -$902K ﹤0.01% 846
2020
Q3 		$876K Sell
97,500
-44,800
-31% -$445K 0.02% 652
2020
Q2 		$1.47M Buy
142,300
+137,300
+2,746% +$1.41M 0.05% 443
2020
Q1 		$50K Sell
5,000
-119,000
-96% -$1.4M ﹤0.01% 790
2019
Q4 		$1.65M Buy
124,000
+104,000
+520% +$1.15M 0.06% 391
2019
Q3 		$171K Buy
20,000
+19,600
+4,900% +$190K 0.01% 598
2019
Q2 		$5K Sell
400
-101,090
-100% -$1.13M ﹤0.01% 637
2019
Q1 		$962K Sell
101,490
-137,310
-58% -$1.53M 0.05% 363
2018
Q4 		$2.07M Buy
+238,800
New +$2.74M 0.17% 175

Other funds holding IRWD

SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Caption Management's IRWD Position: Q1 2025 in Review

Caption Management sold out of Ironwood Pharmaceuticals (IRWD) in Q1 2025, closing a stake of 50,000 shares — an estimated $222K sold.

Caption Management first reported a position in IRWD in Q4 2018 and held it in 13 quarters. The position peaked at $2.27M in Q2 2021. 200 funds tracked by Wall St. Rank hold IRWD as of Q1 2025.

  • Caption Management reported no remaining Ironwood Pharmaceuticals position as of Q1 2025 after selling out during the quarter.
  • Caption Management sold 50,000 Ironwood Pharmaceuticals shares in Q1 2025, an estimated $222K.
  • Caption Management first reported a position in Ironwood Pharmaceuticals in Q4 2018 and held it in 13 quarters.
  • Caption Management's Ironwood Pharmaceuticals position peaked at $2.27M in Q2 2021.
  • 200 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q1 2025.

Based on Caption Management's 13F filing for Q1 2025, filed 15 May 2025.